These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4406492)

  • 1. [Behavior of immunoreactive insulin, "big insulin" and the somatotropic hormone in cirrhotic patients with diabetes mellitus].
    Gragnoli G; Genazzani AR; Tanganelli I; Palazzuoli V; Felber JP
    Folia Endocrinol; 1974 Apr; 27(2):196-211. PubMed ID: 4406492
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum glucose, insulin, and growth hormone in chronic hepatic cirrhosis.
    Samaan NA; Stone DB; Eckhardt RD
    Arch Intern Med; 1969 Aug; 124(2):149-52. PubMed ID: 5797073
    [No Abstract]   [Full Text] [Related]  

  • 3. [Serum insulin and growth hormone during glucose loading in liver cirrhosis].
    Schatz H; Paumgartner G; Brunner H; Höfer R; Grabner G
    Wien Z Inn Med; 1971; 52(1):41-6. PubMed ID: 5540818
    [No Abstract]   [Full Text] [Related]  

  • 4. Glucose resistance contributes to diabetes mellitus in cirrhosis.
    Petrides AS; Schulze-Berge D; Vogt C; Matthews DE; Strohmeyer G
    Hepatology; 1993 Aug; 18(2):284-91. PubMed ID: 8340056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cirrhosis and diabetes. V. Serum human growth hormone levels in Laennec's cirrhosis.
    Conn HO; Daughaday WH
    J Lab Clin Med; 1970 Oct; 76(4):678-88. PubMed ID: 5458029
    [No Abstract]   [Full Text] [Related]  

  • 6. [Diabetes mellitus and reduced glucose tolerance in liver cirrhosis].
    Sestoft L
    Nord Med; 1968 Aug; 80(33):1073-9. PubMed ID: 5685663
    [No Abstract]   [Full Text] [Related]  

  • 7. [Changes of glycemia, insulinemia (IRI), and non-esterified free fatty acids during dynamic tests in a group of subjects with hepatic cirrhosis. The Rastinon test].
    Zandomeneghi R
    Minerva Med; 1970 Jan; 61(6):185-9. PubMed ID: 5412764
    [No Abstract]   [Full Text] [Related]  

  • 8. Malnutrition and diabetes mellitus are related to hepatic encephalopathy in patients with liver cirrhosis.
    Kalaitzakis E; Olsson R; Henfridsson P; Hugosson I; Bengtsson M; Jalan R; Björnsson E
    Liver Int; 2007 Nov; 27(9):1194-201. PubMed ID: 17919230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [On the physiopathology of insulin production. 3. Changes in immuno-reactive insulin after oral administration of glucose in normal subjects and subjects with pancreatic diabetes].
    Peschle C; Rengo F; Saccà L; Trimarchi F; Carducci A; Ferraù O; Condorelli M
    Folia Endocrinol; 1969 Dec; 22(4):452-79. PubMed ID: 5409266
    [No Abstract]   [Full Text] [Related]  

  • 10. [Differential diagnosis of diabetes mellitus caused by liver cirrhosis and other type 2 diabetes mellitus].
    Kim MG; Choi WC
    Korean J Hepatol; 2006 Dec; 12(4):524-9. PubMed ID: 17237630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver transplantation in cirrhotic patients with diabetes mellitus.
    Haydon G; Neuberger J
    Liver Transpl; 2001 Mar; 7(3):234-7. PubMed ID: 11244165
    [No Abstract]   [Full Text] [Related]  

  • 12. [Changes of glycemia, immunoreactive insulin and nonesterified free fatty acids during function tests in a group of subjects with liver cirrhosis].
    Zandomeneghi R; Sgarbi E; Piva R
    Minerva Gastroenterol; 1969; 15(4):191-4. PubMed ID: 5379887
    [No Abstract]   [Full Text] [Related]  

  • 13. [Somatotropic function of the cirrhotic patient].
    Rüedi B; Aubert M; Borel GA; Magnenat P; Felber JP
    Schweiz Med Wochenschr; 1969 Jul; 99(31):1119-21. PubMed ID: 5406977
    [No Abstract]   [Full Text] [Related]  

  • 14. [Decrease of insulin resistance after splenectomy in a diabetic patient with liver cirrhosis and portal hypertension. Physiopathologic evaluation].
    Moro E; Pais M; Benvegnù M; Ferrari M; Bittolo Bon G
    Minerva Gastroenterol Dietol; 1994 Dec; 40(4):213-8. PubMed ID: 7849151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of transjugular intrahepatic portosystemic shunt (TIPS) on glycemic control in cirrhotic patients with diabetes mellitus.
    Deschênes M; Somberg KA
    Am J Gastroenterol; 1998 Mar; 93(3):483. PubMed ID: 9517672
    [No Abstract]   [Full Text] [Related]  

  • 16. Glucose kinetics and splanchnic uptake following mixed meal ingestion in cirrhotic-diabetic subjects.
    Kiwanuka E; Barazzoni R; Tessari P
    Diabetes Nutr Metab; 2001 Dec; 14(6):315-24. PubMed ID: 11853363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Behavior of the insulinemic response after oral and intravenous administration of glucose in the normal subject and obese diabetic].
    Laudicina E; Bompiani GD; Scaduto P; Cerasola GA; Angileri G
    Folia Endocrinol; 1969 Dec; 22(4):400-16. PubMed ID: 5409263
    [No Abstract]   [Full Text] [Related]  

  • 18. [Changes in carbohydrate metabolism, plasmatic NEFA and immunoreactive insulin in hepatic cirrhosis].
    Gragnoli G; Pupillo A; Montagnani M; Bayeli PF
    Atti Accad Fisiocrit Siena Med Fis; 1968; 17(2):1373-90. PubMed ID: 5759915
    [No Abstract]   [Full Text] [Related]  

  • 19. [Behavior of plasma IRI, HGH and cortisol after administration of levodopa in patients with hepatic cirrhosis].
    Palazzuoli V; Gragnoli G; Favilli R; Tanganelli I; Migliarese G
    Boll Soc Ital Biol Sper; 1976 May; 52(9):630-5. PubMed ID: 949450
    [No Abstract]   [Full Text] [Related]  

  • 20. Does gonadotropin-releasing hormone administration affect serum growth hormone levels in poorly controlled insulin-dependent and non-insulin-dependent diabetes mellitus?
    Gürlek A; Yordam N; Telatar F
    Isr J Med Sci; 1995 Nov; 31(11):685-9. PubMed ID: 7591703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.